Hsp90/Aha1 small molecule disruptors could effectively treat neurodegenerative diseases, however all compounds previously mentioned exhibit poor physiochemical properties including permeability and blood–brain-barrier penetrance. Here, HSP90AA1 is linked to neurodegenerative disease.